Woodcock’s legacy, plus Frazier, Bain & the Distillery

Emerging Company Spotlight: MoonLake, Walden

On the latest BioCentury This Week podcast, BioCentury’s editors discuss how Janet Woodcock has reshaped the way drugs are regulated and developed during her more than three decades at FDA. They also dig into how Bain and Frazier Healthcare Partners plan to deploy their new funds, the most recent translational offerings in BioCentury’s Distillery,and Emerging Company Profiles for MoonLake Immunotherapeutics AG and Walden Biosciences Inc.